Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Fernandez

Showing results (201-210 of 202) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 202 results.
Revista De Neurologia|September 7, 2013
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)O Fernandez, C Arnal-Garcia, R Arroyo-Gonzalez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2017
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker studyV Conteduca, D Wetterskog, M T A Sharabiani, et al.
Pageof 21

Showing results (201-210 of 202) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 202 results.
Revista De Neurologia|September 7, 2013
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)O Fernandez, C Arnal-Garcia, R Arroyo-Gonzalez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2017
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker studyV Conteduca, D Wetterskog, M T A Sharabiani, et al.
Pageof 21